Xiangyu Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Regulatory T Cells

Drug Administration

Top Venues

Journal of medicinal chemistry

Natural product reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Xiangyu Zhang
Vallesamidine and schizozygane alkaloids: rearranged monoterpene indole alkaloids and synthetic endeavours. Natural product reports 41 (5) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry (2024)
Xiangyu Zhang
Vallesamidine and schizozygane alkaloids: rearranged monoterpene indole alkaloids and synthetic endeavours. Natural product reports (2024)
Xiangyu Zhang
Vallesamidine and schizozygane alkaloids: rearranged monoterpene indole alkaloids and synthetic endeavours. Natural product reports 41 (5) (2024)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kuojun Zhang, Ke Ye, He Tang, Zhihao Qi, Tianyu Wang, Jie Mao, Xiangyu Zhang, Sheng Jiang
Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors. Journal of medicinal chemistry (2023)
Tianyu Wang, Kaizhen Wang, Yu Zhang, Kuojun Zhang, Shi Cai, Sheng Jiang, Yibei Xiao, Xiangyu Zhang
Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA). Journal of medicinal chemistry (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry (2023)